|
G |
App |
amyloid beta precursor protein |
multiple interactions affects expression increases expression |
EXP |
Dihydrotestosterone promotes the reaction [Trenbolone Acetate analog results in increased expression of APP protein modified form]; Flutamide inhibits the reaction [Trenbolone Acetate analog results in increased expression of APP protein modified form]; fulvestrant inhibits the reaction [Trenbolone Acetate analog results in increased expression of APP protein modified form]; trilostane inhibits the reaction [Dihydrotestosterone promotes the reaction [Trenbolone Acetate analog results in increased expression of APP protein modified form]] Trenbolone Acetate analog affects the expression of APP protein modified form |
CTD |
PMID:25461682 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Ar |
androgen receptor |
multiple interactions affects binding increases activity |
ISO EXP |
Trenbolone Acetate binds to and results in increased activity of AR protein; Trenbolone Acetate inhibits the reaction [Metribolone results in increased activity of AR protein]; triclocarban promotes the reaction [Trenbolone Acetate results in increased activity of AR protein] Trenbolone Acetate binds to AR protein |
CTD |
PMID:14565775 PMID:16818248 PMID:18324785 PMID:20371976 PMID:20821581 PMID:33049310 More...
|
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
EXP |
Dihydrotestosterone promotes the reaction [Trenbolone Acetate analog results in increased activity of CASP3 protein]; Flutamide promotes the reaction [Trenbolone Acetate analog results in increased activity of CASP3 protein]; fulvestrant affects the reaction [Trenbolone Acetate analog results in increased activity of CASP3 protein]; Testosterone promotes the reaction [Trenbolone Acetate analog results in increased activity of CASP3 protein]; trilostane inhibits the reaction [Dihydrotestosterone promotes the reaction [Trenbolone Acetate analog results in increased activity of CASP3 protein]] |
CTD |
PMID:25461682 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
Trenbolone Acetate binds to and results in increased activity of ESR1 protein |
CTD |
PMID:33049310 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
Trenbolone Acetate binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:33049310 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Odc1 |
ornithine decarboxylase 1 |
increases expression |
EXP |
Trenbolone Acetate results in increased expression of ODC1 mRNA |
CTD |
PMID:17688994 |
|
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
|
|
G |
Psen1 |
presenilin 1 |
multiple interactions decreases expression |
EXP |
Flutamide inhibits the reaction [Trenbolone Acetate analog results in decreased expression of PSEN1 protein]; fulvestrant inhibits the reaction [Trenbolone Acetate analog results in decreased expression of PSEN1 protein]; Testosterone affects the reaction [Trenbolone Acetate analog results in decreased expression of PSEN1 protein]; Trenbolone Acetate analog inhibits the reaction [Dihydrotestosterone results in increased expression of PSEN1 protein]; trilostane inhibits the reaction [Trenbolone Acetate analog inhibits the reaction [Dihydrotestosterone results in increased expression of PSEN1 protein]] |
CTD |
PMID:25461682 |
|
NCBI chr 6:103,323,052...103,375,088
Ensembl chr 6:103,323,120...103,371,650
|
|
G |
Thrb |
thyroid hormone receptor beta |
multiple interactions |
ISO |
Trenbolone Acetate binds to and results in increased activity of THRB protein |
CTD |
PMID:33049310 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|